Cargando…
Pituitary adenylate cyclase-activating polypeptide prevents contrast-induced nephropathy in a novel mouse model
We determined whether pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) prevents contrast-induced nephropathy using human renal proximal tubule epithelial (HK-2) cells and homozygous endothelial nitric oxide synthase-deficient (eNOS(−/−)) mice as a novel in vivo model. Cultured HK-2 ce...
Autores principales: | Khan, Altaf-M, Maderdrut, Jerome L, Li, Min, Toliver, Herman L, Coy, David H, Simon, Eric E, Batuman, Vecihi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871477/ https://www.ncbi.nlm.nih.gov/pubmed/24400164 http://dx.doi.org/10.1002/phy2.163 |
Ejemplares similares
-
Pituitary adenylate cyclase activating polypeptide and migraine
por: Zagami, Alessandro S, et al.
Publicado: (2014) -
Pituitary Adenylate Cyclase-Activating Polypeptide in Learning and Memory
por: Gilmartin, Marieke R., et al.
Publicado: (2021) -
Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
por: Cardoso, João C. R., et al.
Publicado: (2020) -
Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
por: Horvath, Gabriella, et al.
Publicado: (2022) -
Role of pituitary adenylate cyclase‐activating polypeptide in modulating hypothalamic‐pituitary system
por: Oride, Aki, et al.
Publicado: (2018)